Home Submit URL Add to Favorite Contact
           24 April, 2024
 
    
Health » Pharmacy » Drugs and Medications » C

UPDATE INFO | REPORT BROKEN LINK

Stalevo (carbidopa, levodopa and entacapone) - Novartis

Popularity:    Hit: 918
Details:
Official pharmaceutical site for this combination product for the treatment of Parkinson's disease.
URL: http://www.stalevo.com
Title: Pharmaceutical Products | pharma.us.novartis.com
Image:
Description: Health, Pharmacy, Drugs and Medications, C - Stalevo (carbidopa, levodopa and entacapone) - Novartis. Official pharmaceutical site for this combination product for the treatment of Parkinson's disease.
Similar:

Related Sites 
Pletal (Popularity: ): The newest medication for temporary relief of intermittent claudication, caused by Peripheral Arterial Disease.
Evoxac - Daiichi Pharmaceutical Co (Popularity: ): Official pharmaceutical site with education and treatment information for patients and health professionals.
Miacalcin (Popularity: ): Calcitonin-salmon. Nasal Spray by Novartis Pharmaceuticals for women with osteoporosis, that are at least 5 years past menopause.
Nutritional Treatment of Lice (Popularity: ): Offers information about calcium and its deficiency. Includes the cell salts and other conditions.
Vivarin (Popularity: ): Includes product information for the alertness aid.
Plavix (Popularity: ): Indicated for the reduction of atherosclerotic events (myocardial infarction, stroke and vascular death) in patients with atherosclerosis documented by recent ...
Premarin.org (Popularity: ): Features history of the drug, background of Wyeth-Ayerst, HRT information, and information about the controversy surrounding the mares used in ...
Caltrate (Popularity: ): Information on this company's calcium supplements.
Zyrtec (Popularity: ): Cetirizine HCl and pseudoephedrine HCl.
Cipro USA (Popularity: ): Ciprofloxacin details from Bayer Pharmaceuticals. Information about the antibiotic prescribed for urinary tract infection, prostatitis, cystitis, bacterial infections, and infectious ...
Desitin (Popularity: ): Diaper rash treatment. Includes information about common skin problems in babies.


Popular Sites
Calciuminfo.com (Popularity: ): Online calcium resource from the makers of Tums.
Coral Calcium and the Deep Down Truth (Popularity: ): An article that disputes advertisers' claims about the so-called benefits of this supplement.
Celebrex (Popularity: ): A source of information about relief from arthritis pain including Osteoarthritis and Rheumatoid Arthritis. A nonsteroidal anti-inflammatory drug, product information ...
Evoclin (Popularity: ): The official site for this topical treatment based on 1% clindamycin phosphate foam. Contains detailed prescribing and application information for ...
Stalevo (carbidopa, levodopa and entacapone) - Novartis (Popularity: ): Official pharmaceutical site for this combination product for the treatment of Parkinson's disease.


Related Press
Novartis committed to making GalvusĀ® available for patients with type 2 diabetes after US regulators issue "approvable letter" (Popularity: ): * Novartis confident in safety and efficacy of Galvus as a once-daily oral treatment for patients with type 2 diabetes, ...
4-Antibody AG Closes CHF 6 Million Series A Financing and Appoints Sijmen de Vries as CEO (Popularity: ): 4-Antibody, a Basel-based biotechnology company focused on exploiting its proprietary platform to develop de novo and improved fully human antibodies, ...
Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 (Popularity: ): Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
FDA Approves Vaccines for the 2010-2011 Influenza Season (Popularity: ): The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the ...